Смотри, что у тебя внутри - Страница 28

61

J. Douwes et al., “Does Early Indoor Microbial Exposure Reduce the Risk of Asthma? The Prevention and Incidence of Asthma and Mite Allergy Birth Cohort Study,” Journal of Allergy and Clinical Immunology 117, no. 5 (May 2006): 1067–73.

62

S. Lau et al., “Early Exposure to House-Dust Mite and Cat Allergens and Development of Childhood Asthma: a Cohort Study. Multicenter Allergy Study Group,” The Lancet 356, no. 9239 (Oct. 21, 2000): 1392–7.

63

M. J. Ege et al., “Exposure to Environmental Microorganisms and Childhood Asthma,” New England Journal of Medicine 364, no. 8 (Feb. 24, 2011): 701–9.

64

E. Y. Hsiao et al., “Microbiota Modulate Behavioral and Physiological Abnormalities Associated With Neurodevelopmental Disorders,” Cell 155, no. 7 (Dec. 19, 2013): 1451–63.

65

N. Elazab et al., “Probiotic Administration in Early Life, Atopy, and Asthma: a Meta-Analysis of Clinical Trials,” Pediatrics 132, no. 3 (Sept. 2013): 666–76.

66

A. A. Niccoli et al., “Preliminary Results on Clinical Effects of Probiotic Lactobacillus Salivarius LS01 in Children Affected by Atopic Dermatitis,” Journal of Clinical Gastroenterology 48, supplement 1 (Nov-Dec 2014): S34–6.

67

M. C. Arrieta and B. Finlay, “The Intestinal Microbiota and Allergic Asthma,” Journal of Infection 4453, no. 14 (Sept. 25, 2014): 227–8.

68

A. Du Toit, “Microbiome: Clostridia Spp. Combat Food Allergy in Mice,” National Review of Microbiology 12, no. 10 (Sept. 16, 2014): 657.

69

A. T. Stefka et al., “Commensal Bacteria Protect Against Food Allergen Sensitization,” Proceedings of the National Academy of Sciences 111, no. 36 (Sept. 9, 2014): 13145–50.

70

M. Noval Rivas et al., “A Microbiota Signature Associated With Experimental Food Allergy Promotes Allergic Sensitization and Anaphylaxis,” Journal of Allergy and Clinical Immunology 131, no. 1 (Jan. 2013): 201–12.

71

M. S. Kramer et al., “Promotion of Breastfeeding Intervention Trial (PROBIT): a ClusterRandomized Trial in the Republic of Belarus. Design, Follow-Up, and Data Validation,” Advances in Experimental Medicine and Biology 478 (2000): 327–45.

72

H. Kronborg et al., “Effect of Early Postnatal Breastfeeding Support: a Cluster-Randomized Community Based Trial,” Acta Pediatrica 96, no. 7 (July 2007): 1064–70.

73

I. Hanski et al., “Environmental Biodiversity, Human Microbiota, and Allergy Are Interrelated,” Proceedings of the National Academy of Sciences 109, no. 21 (May 22, 2012): 8334–9.

74

C. G. Carson, “Risk Factors for Developing Atopic Dermatitis,” Danish Medical Journal 60, no. 7 (July 2013): B4687.

75

E. von Mutius et al., “The PASTURE Project: E. U. Support for the Improvement of Knowledge About Risk Factors and Preventive Factors for Atopy in Europe,” Allergy 61, no. 4 (April 2006): 407–13.

76

S. J. Song et al., “Cohabiting Family Members Share Microbiota With One Another and With Their Dogs,” eLife 2 (April 16, 2013).

77

B. Brunekreef et al., “Exposure to Cats and Dogs, and Symptoms of Asthma, Rhinoconjunctivitis, and Eczema,” Epidemiology 23, no. 5 (Sept. 2012): 742–50.

78

I. Trehan et al., “Antibiotics as Part of the Management of Severe Acute Malnutrition,” New England Journal of Medicine 368, no. 5 (January 31, 2013): 425–35.

79

M. I. Smith et al., “Gut Microbiomes of Malawian Twin Pairs Discordant for Kwashiorkor,” Science 339, no. 6119 (February 1, 2013): 548–54.

80

Turnbaugh et al., “Core Gut Microbiome in Obese and Lean Twins.”

81

D. N. Frank et al., “MolecularPhylogenetic Characterization of Microbial Community Imbalances in Human Inflammatory Bowel Diseases,” Proceedings of the National Academy of Sciences of the United States of America 104, no. 34 (August 21, 2007): 13780–85; M. Tong et al., “A Modular Organization of the Human Intestinal Mucosal Microbiota and Its Association with Inflammatory Bowel Disease,” PloS One 8, no. 11 (November 19, 2013): e80702.

82

J. U. Scher et al., “Expansion of Intestinal Prevotella Copri Correlates with Enhanced Susceptibility to Arthritis,” eLife 2 (November 5, 2013): e01202.

83

P. Bercik, “The MicrobiotaGut-Brain Axis: Learning from Intestinal Bacteria?”, Gut 60, no. 3 (March 2011): 288–89.

84

J. F. Cryan and S. M. O’Mahony, “The Microbiome-Gut-Brain Axis: From Bowel to Behavior,” Neurogastroenterology and Motility: The Official Journal of the European Gastrointestinal Motility Society 23, no. 3 (March 2011): 187–92.

85

A. Naseribafrouei et al., “Correlation Between the Human Fecal Microbiota and Depression,” Neurogastroenterology and Motility: The Official Journal of the European Gastrointestinal Motility Society 26, no. 8 (August 2014): 1155–62.

86

G. A. Rook, C. L. Raison, and C. A. Lowry, “Microbiota, Immunoregulatory Old Friends and Psychiatric Disorders,” Advances in Experimental Medicine and Biology 817 (2014): 319–56.

87

D. W. Kang et al., “Reduced Incidence of Prevotella and Other Fermenters in Intestinal Microflora of Autistic Children,” PLoS One 8, no. 7 (2013): e68322.

88

Hsiao et al., “Microbiota Modulate Behavioral and Physiological Abnormalities Associated with Neurodevelopmental Disorders.”

89

Vijay-Kumar et al., “Metabolic Syndrome and Altered Gut Microbiota in Mice Lacking Tolllike Receptor 5.”

90

P. Bercik et al., “The Intestinal Microbiota Affect Central Levels of Brain-Derived Neurotropic Factor and Behavior in Mice,” Gastroenterology 141, no. 2 (August 2011): 599–609, 609 e1–3.

91

R. Diaz Heijtz et al., “Normal Gut Microbiota Modulates Brain Development and Behavior,” Proceedings of the National Academy of Sciences of the United States of America 108, no. 7 (February 15, 2011): 3047–52.

92

C. L. Ohland et al., “Effects of Lactobacillus Helveticus on Murine Behavior Are Dependent on Diet and Genotype and Correlate with Alterations in the Gut Microbiome,” Psychoneuroendocrinology 38 (2013): 1738–47.

93

A. R. Mackos et al., “Probiotic Lactobacillus Reuteri Attenuates the Stressor-Enhanced Sensitivity of Citrobacter Rodentium Infection,” Infection and Immunity 81, no. 9 (September 2013): 3253–63.

94

P. A. Kantak, D. N. Bobrow, and J. G. Nyby, “Obsessive-Compulsive-like Behaviors in House Mice Are Attenuated by a Probiotic (Lactobacillus Rhamnosus GG),” Behavioural Pharmacology 25, no. 1 (February 2014): 71–79.

95

Hsiao et al., “Microbiota Modulate Behavioral and Physiological Abnormalities Associated with Neurodevelopmental Disorders.”

96

S. Guandalini et al., “VSL#3 Improves Symptoms in Children with Irritable Bowel Syndrome: A Multicenter, Randomized, Placebo-Controlled, DoubleBlind, Crossover Study,” Journal of Pediatric Gastroenterology and Nutrition 51, no. 1 (July 2010): 24–30.

97

M. Dapoigny et al., “Efficacy and Safety Profile of LCR35 Complete Freeze-Dried Culture in Irritable Bowel Syndrome: A Randomized, Double-Blind Study,” World Journal of Gastroenterology 18, no. 17 (May 7, 2012): 2067–75.

98

E. Smecuol et al., “Exploratory, Randomized, Double-Blind, Placebo-Controlled Study on the Effects of Bifidobacterium Infantis Natren Life Start Strain Super Strain in Active Celiac Disease,” Journal of Clinical Gastroenterology 47, no. 2 (February 2013): 139–47.

99

M. Fr mont et al., “HighThroughput 16S rRNA Gene Sequencing Reveals Alterations of Intestinal Microbiota in Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome Patients,” Anaerobe 22 (August 2013): 50–56.

100

M. Messaoudi et al., “Beneficial Psychological Effects of a Probiotic Formulation (Lactobacillus Helveticus R0052 and Bifidobacterium Longum R0175) in Healthy Human Volunteers,” Gut Microbes 2, no. 4 (July/August 2011): 256–61.

101

Medical Council, General Board of Health, Report of the Committee for Scientific Inquiries in Relation to the Cholera-Epidemic of 1854 (London, England, 1855).

102

C. A. Lozupone et al., “Diversity, Stability and Resilience of the Human Gut Microbiota,” Nature 489, no. 7415 (September 13, 2012): 220–30.